You have 9 free searches left this month | for more free features.

Anaplastic oligodendroglioma

Showing 1 - 25 of 521

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Withdrawn
    • Recurrent Anaplastic Astrocytoma
    • +7 more
    • Neural Stem Cells-expressing CRAd-S-pk7
    • Resection
    • (no location specified)
    Nov 22, 2022

    Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

    Active, not recruiting
    • Brain Tumor, Recurrent
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • New York, New York
    • +1 more
    Jun 9, 2022

    Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

    Recruiting
    • Recurrent High-grade Glioma
    • +3 more
    • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
    • +2 more
    • Incheon, Korea, Republic of
      Gachon University Gil Medical Center
    Feb 19, 2023

    CNS Cancer, CNS BRAIN Trial in Basking Ridge, Commack, New York (temozolomide followed by high dose busulfan and thiotepa)

    Active, not recruiting
    • CNS Cancer
    • CNS BRAIN
    • temozolomide followed by high dose busulfan and thiotepa
    • Basking Ridge, New Jersey
    • +2 more
    Oct 7, 2021

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Active, not recruiting
    • Recurrent Anaplastic Astrocytoma
    • +6 more
    • Carboxylesterase-expressing Allogeneic Neural Stem Cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

    Recruiting
    • Central Nervous System Neoplasms
    • +22 more
    • Bethesda, Maryland
      National Institutes of Health
    Mar 1, 2022

    Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

    Recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
    • +2 more
    Jul 8, 2022

    Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

    Completed
    • Anaplastic Oligoastrocytoma
    • +3 more
    • Minneapolis, Minnesota
    • +1 more
    Mar 11, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

    Active, not recruiting
    • Childhood Astrocytoma
    • +9 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 8, 2022

    Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

    Active, not recruiting
    • Adult Anaplastic Astrocytoma
    • +15 more
    • biopsy
    • +7 more
    • Rochester, Minnesota
      Mayo Clinic
    Apr 8, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

    Not yet recruiting
    • Glioblastoma Multiforme
    • +4 more
    • SIACI of cetuximab and bevacizumab
    • Miami, Florida
      Jackson Memorial Hospital
    Jul 14, 2023

    Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Los Angeles, California
    • +11 more
    Jul 1, 2022

    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

    Completed
    • Adult Anaplastic Astrocytoma
    • +6 more
    • E. coli CD-expressing genetically modified neural stem cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Sep 28, 2021

    MicroRNA-10b in Patients With Gliomas

    Recruiting
    • Astrocytoma
    • +8 more
      • Boston, Massachusetts
      • +3 more
      May 30, 2021

      Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

      Completed
      • Adult Anaplastic Astrocytoma
      • +8 more
      • Laboratory Biomarker Analysis
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 28, 2021

      Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

      Recruiting
      • Grade II Glioma
      • +7 more
      • Microdevice
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Feb 22, 2021

      Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

      Withdrawn
      • Anaplastic Oligodendroglioma
      • +2 more
      • Wear novoTTF-200A
      • Quality-of-Life Assessment
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Dec 8, 2020

      Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

      Recruiting
      • Oligodendroglioma
      • +2 more
      • Radiation therapy
      • Oslo, Norway
        Oslo University Hospital
      Jan 14, 2022